Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin versus Prostaglandins for Labor Induction with Unfavorable Cervix (OPIC)
2024-517675-20-00Phase 4Authorised
- Sponsor
- CHRU Tours
- Start
- Dec 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of oxytocin in induced labor (2 arms), sponsored by CHRU Tours. Primary endpoint: Rate of caesarean delivery. Planned start Dec 2024; status: authorised.
02
Drugs
oxytocin
03
Conditions
induced labor
Beyond the preview
Go deeper on 2024-517675-20-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-517675-20-00.